Testing and validation of the Russian version of quality of life questionnaire in patients with GERD – GERD-HRQL

Cover Page

Cite item

Full Text

Abstract

Aim. This study aimed to test the Russian version of GERD-HRQL in the focus group of patients with GERD, as well as to evaluate its psychometric properties – reliability, validity and sensitivity.

Materials and methods. The total of 57 patients with GERD (mean age – 45.8±12.4 years, 72% – women, 68% – patients with not erosive reflux disease, 84% had esophageal manifestations of GERD) were enrolled into the study. All the patients filled out the Russian version of GERD-HRQL and generic quality of life questionnaire RAND SF-36 during the routine visit to the gastroenterologist. According to the results of testing of GERD-HRQL, it was clear and easy to complete for patients and reflected the main concerns specific for GERD patients. The most frequent and bothersome symptoms/problems which interfered with quality of life in GERD patients were heartburn (100% of patients) and bloating (84% of patients). During the validation procedure, the high reliability and validity of the Russian version of GERD-HRQL were demonstrated. It was shown that the tool was sensitive both to changes over time and to clinically determined differences in patients’ status.

Results. The Total GERD-HRQL Score was significantly higher (worse quality of life) in the following groups: a) patients who had esophageal manifestations of GERB vs those without esophageal manifestations of GERB; b) patients with GERD complications vs those without GERD complications, c) patients with comorbidities of upper gastrointestinal tract vs without those comorbidities; d) patients with erosive esophagitis vs with non-erosive reflux disease (p<0.05).

Conclusion. The developed Russian version of the GERD-HRQL questionnaire proved to have high psychometric properties and may be used in the Russian population of GERD patients both in research studies and in a real clinical practice.

About the authors

T. I. Ionova

Saint Petersburg State University Hospital; Multinational Center for Quality of Life Research

Email: tnikitina_74@mail.ru
ORCID iD: 0000-0002-9431-5286

д.б.н., проф., рук. отд., председатель совета 

Russian Federation, Saint Petersburg

A. V. Zinkovskaya

Multinational Center for Quality of Life Research

Email: tnikitina_74@mail.ru
ORCID iD: 0000-0002-7028-0496

специалист по биостатистике

Russian Federation, Saint Petersburg

E. A. Mayevskaya

Yevdokimov Moscow State University of Medicine and Dentistry

Email: tnikitina_74@mail.ru
ORCID iD: 0000-0002-3323-3279

к.м.н., ассистент каф.

Russian Federation, Moscow

T. P. Nikitina

Saint Petersburg State University Hospital; Multinational Center for Quality of Life Research

Author for correspondence.
Email: tnikitina_74@mail.ru
ORCID iD: 0000-0002-8279-8129

к.м.н., врач-методист, рук. отд.

Russian Federation, Saint Petersburg

N. M. Porfirieva

Multinational Center for Quality of Life Research

Email: tnikitina_74@mail.ru
ORCID iD: 0000-0003-3329-2743

науч. сотр.

Russian Federation, Saint Petersburg

N. V. Cheremushkina

Yevdokimov Moscow State University of Medicine and Dentistry

Email: tnikitina_74@mail.ru
ORCID iD: 0000-0002-6387-1001

к.м.н., ассистент

Russian Federation, Moscow

R. I. Shaburov

Yevdokimov Moscow State University of Medicine and Dentistry; Central Clinic Hospital “RZD-Medicine”

Email: tnikitina_74@mail.ru
ORCID iD: 0000-0001-9741-0150

к.м.н., ассистент, глав. врач 

Russian Federation, Moscow

Yu. A. Kucheryavyy

Yevdokimov Moscow State University of Medicine and Dentistry; Ilyinsky Hospital

Email: tnikitina_74@mail.ru
ORCID iD: 0000-0001-7760-2091

к.м.н., доц. каф., зав. отд-нием 

Russian Federation, Moscow

I. V. Maev

ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России

Email: tnikitina_74@mail.ru
ORCID iD: 0000-0001-6114-564X

Yevdokimov Moscow State University of Medicine and Dentistry

Russian Federation, Moscow

References

  1. Маев И.В., Кучерявый Ю.А. Достижения в диагностике и лечении гастроэзофагеальной рефлюксной болезни. Фарматека. 2007;2:49-52 [Maev IV, Kucheryavyy UA. Advances in the diagnosis and treatment of gastroesophageal reflux disease. Farmateca. 2007;2:49-52 (In Russ.)].
  2. Ивашкин В.Т., Маев И.В., Трухманов А.С. и др. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению гастроэзофагеальной рефлюксной болезни. Рос. журн. гастроэнтерологии, гепатологии, колопроктологии. 2017;27(4):75-95 [Ivashkin VT, Mayev IV, Trukhmanov AS, et al. Diagnostics and treatment of gastroesophageal reflux disease: clinical guidelines of the Russian gastroenterological association. Rus J Gastroenterol Hepatol Coloproctol. 2017;27(4):75-95 (In Russ.)]. doi: 10.22416/1382-4376-2017-27-4-75-95
  3. Blackshaw LA, Bordin DS, Brock C, et al. Pharmacologic treatments for esophageal disorders. Ann N Y Acad Sci. 2014;1325(1):23-39. doi: 10.1111/nyas.12520
  4. Бордин Д.С. Как выбрать ингибитор протонной помпы больному ГЭРБ? Эксперим. и клин. гастроэнтерология. 2010;2:53-8 [Bordin DS. How to choose a proton pump inhibitor for a patient with gastroesophageal reflux disease? Exp Clin Gastroenterol. 2010;2:53-8 (In Russ.)]
  5. Кайбышева В.О., Кучерявый Ю.А., Трухманов А.С. и др. Результаты многоцентрового наблюдательного исследования по применению международного опросника GerdQ для диагностики гастроэзофагеальной рефлюксной болезни. Рос. журн. гастроэнтерологии, гепатологии, колопроктологии. 2013;(23)5:15-24 [Results of a multicenter observational study on the use of the international GerdQ questionnaire for the diagnosis of gastroesophageal reflux disease. Rus J Gastroenterol Hepatol Coloproctol. 2013;(23)5:15-24 (In Russ.)].
  6. Андреев Д.Н., Кучерявый Ю.А. Перспективы лечения гастроэзофагеальной рефлюксной болезни. Гастроэнтерология (Прил. к журн. Consilium Medicum. 2013;15(2):9-14 [Andreev DN, Kucheryavyy YuA. Prospects for the treatment of gastroesophageal reflux disease. Gastroenterology (Suppl. Consilium Medicum). 2013;15(2):9-14 (In Russ.)].
  7. Маев И.В., Андреев Д.Н., Кучерявый Ю.А., Шабуров Р.И. Современные достижения в лечении гастроэзофагеальной рефлюксной болезни: фокус на эзофагопротекцию. Терапевтический архив. 2019;91(8):4-11 [Maev IV, Andreev DN, Kucheryavyy YA, Shaburov RI. Current advances in the treatment of gastroesophageal reflux disease: a focus on esophageal protection. Therapeutic Archive. 2019;91(8):4-11 (In Russ.)]. doi: 10.26442/00403660.2019.08.000387
  8. Маев И.В., Баркалова Е.В., Овсепян М.А. и др. Возможности рН-импедансометрии и манометрии высокого разрешения при ведении пациентов с рефрактерной гастроэзофагеальной рефлюксной болезнью. Терапевтический архив. 2017;89(2):76-83 [Maev IV, Barkalova EV, Ovsepyan MA, et al. Possibilities of pH impedance and high-resolution manometry in managing patients with refractory gastroesophageal reflux disease. Therapeutic Archive. 2017;89(2):76-83 (In Russ.)].
  9. Velanovich V. The development of the GERD-HRQL symptom severity instrument. Dis Esophagus. 2007;20(2):130-4. doi: 10.1111/j.1442-2050.2007.00658.x
  10. Velanovich V, Vallance SR, Gusz JR, et al. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg. 1996;183(3):217-24. doi: 0.1111/j.1442-2050.2007.00658.x
  11. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186-91. doi: 10.1097/00007632-200012150-00014
  12. Ионова Т.И. Принципы языковой и культурной адаптации опросников оценки качества жизни. Вестник Межнационального центра исследования качества жизни. 2018;31-32:12-7 [Ionova TI. Principles of linguistic and cultural adaptation of quality of life questionnaires. Bulletin of Multinational Center for Quality of Life Research. 2018;31-32:12-7 (In Russ.)].
  13. Ионова Т.И., Никитина Т.П., Маевская Е.А. и др. Разработка русской версии опросника для оценки качества жизни у больных ГЭРБ – GERD-HRQL. Терапевтический архив. 2020;92(8) [Ionova TI, Nikitina TP, Mayevskaya EA, et al. Development of the Russian version of quality of life questionnaire in patients with GERD – GERD-HRQL. 2020;92(8) (In Russ.)] doi: 10.26442/00403660. 2020.08.000658
  14. Новик А.А., Ионова Т.И. Руководство по исследованию качества жизни в медицине. М.: РАЕН, 2012 [Novik AA, Ionova TI. Guidelines for Research on Quality of Life in Medicine. Moscow: RAEN, 2012 (In Russ.)].
  15. Chan Y, Ching JYL, Cheung CMY, et al. Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire. Aliment Pharmacol Ther. 2010;31(3):452-60. doi: 10.1111/j.1365-2036.2009.04187.x
  16. Castelijns PS, Ponten JE, Vd Poll MC, et al. Quality of life after Nissen fundoplication in patients with gastroesophageal reflux disease: Comparison between long- and short-term follow-up. J Minim Access Surg. 2018;14(3):213-20. doi: 10.4103/jmas.JMAS_75_17
  17. De Castro Santos G, Da Mota PR, Fabrini DS, et al. Evaluation of Health-Related Quality of Life (HRQL) in Patients with Gastroesophageal Reflux Disease (GERD) Before and After Nissen Fundoplication Surgery. Bras J Videoendoscopic Sur. 2010;3(1):24-9. https://www.sobracil.org.br/revista/jv030301/bjvs030301_024.pdf

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Figure: 1. Distribution of patients in the sample according to the indicators of symptoms / problems according to the GERD-HRQL questionnaire.

Download (258KB)
3. Figure: 2. Average values of the total score for the GERD-HRQL in different groups of patients: a - the presence and absence of esophageal manifestations; b - presence and absence of GERD complications; c - the presence and absence of concomitant pathology of the upper gastrointestinal tract; d - NERD and EE; p <0.05.

Download (196KB)
4. Figure: 3. Average values of the total score on the GERD-HRQL before and 4 weeks after the start of GERD therapy; p <0.001.

Download (66KB)

Copyright (c) 2020 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies